CollPlant Biotechnologies (CLGN) Enterprise Value (2017 - 2025)
CollPlant Biotechnologies (CLGN) posted Enterprise Value of -$5.9 million for Q4 2025, up 49.18% on a QoQ basis from -$11.7 million in Q2 2025, and up 97.71% year-over-year from -$3.0 million in Q4 2024.
CollPlant Biotechnologies (CLGN) Enterprise Value (2017 - 2025) Analysis & Trends
CollPlant Biotechnologies' Enterprise Value history runs 9 years deep, the most recent figure standing at -$5.9 million for Q4 2025.
- Quarterly Enterprise Value rose 97.71% year-over-year to -$5.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$5.9 million (up 97.71% YoY) and the FY2025 annual result came in at -$5.9 million, up 97.71% from the prior year.
- Enterprise Value was -$5.9 million for Q4 2025 at CollPlant Biotechnologies, up from -$11.7 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$5.9 million in Q4 2025 and bottomed at -$213.0 billion in Q4 2021.
- A 5-year average of -$11.9 billion and a median of -$34.8 million in 2022 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2021 — Enterprise Value sank 5746140.84% — and 2022, when it jumped 99.9%.
- CollPlant Biotechnologies' Enterprise Value stood at -$213.0 billion in 2021, then soared by 99.9% to -$217.9 million in 2022, then jumped by 87.65% to -$26.9 million in 2023, then slumped by 865.67% to -$259.9 million in 2024, then surged by 97.71% to -$5.9 million in 2025.
- Business Quant data shows CLGN's Enterprise Value at -$5.9 million in Q4 2025, -$11.7 million in Q2 2025, and -$259.9 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | -61.40 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -2.83 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | -4.79 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -1.91 Bn |
| 10 | CollPlant Biotechnologies | 4.63 Mn | 4.63 Mn | -243,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -5.95 Mn |
| Jun 30, 2025 | -11.71 Mn |
| Dec 31, 2024 | -259.91 Mn |
| Sep 30, 2024 | -256.37 Mn |
| Jun 30, 2024 | -19.16 Mn |
| Mar 31, 2024 | -265.67 Mn |
| Dec 31, 2023 | -26.92 Mn |
| Sep 30, 2023 | -254.98 Mn |
| Jun 30, 2023 | -22.60 Mn |
| Mar 31, 2023 | -30.10 Mn |
| Dec 31, 2022 | -217.86 Mn |
| Sep 30, 2022 | -33.00 Mn |
| Jun 30, 2022 | -36.69 Mn |
| Mar 31, 2022 | -41.50 Mn |
| Dec 31, 2021 | -213.01 Bn |
| Sep 30, 2021 | -26.18 Mn |
| Jun 30, 2021 | -17.85 Mn |
| Mar 31, 2021 | -193.91 Mn |
| Dec 31, 2020 | -3.71 Mn |
| Sep 30, 2020 | -5.39 Mn |